Frequencies of the G-protein β3 subunit C825T polymorphism and the δ 32 mutation of the chemokine receptor-5 in patients with multiple sclerosis

被引:17
作者
Haase, CG
Schmidt, S
Faustmann, PM
机构
[1] Univ Hosp Essen, Dept Neurol, Essen, Germany
[2] Univ Hosp Bonn, Dept Neurol, Bonn, Germany
[3] Ruhr Univ Bochum, Dept Neuroanat & Mol Brain Res, D-4630 Bochum, Germany
关键词
multiple sclerosis; genetics; G-protein; chemokine receptor; Delta 32 chemokine receptors 5; chemotaxis;
D O I
10.1016/S0304-3940(02)00807-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
In the pathogenesis of multiple sclerosis (MS) genetic factors are known to influence autoreactive T-cell-actions like proliferation and chemotaxis across the blood-brain barrier via chemokine receptors (CCR) and G-protein coupled activating mechanisms. For the first time, we studied the frequencies of a recently described C825T polymorphism in the G-protein encoding gene for the,83 subunit (GNB3) together with frequencies of a 32-base-pair deletion in the CCR5 gene (832 CCR5) in patients with MS (n = 253: relapsing-remitting (1313), n = 124 and chronic progressive course, n = 129). Apart from a trend to a reduced frequency of 832 CCR5 and increased GNB3 825T polymorphism in primary chronic progressive patients, numbers did not reach statistical significance in any group of MS. These results could not support differences in the genetic background of MS based on that CCR5 mutation or the described GNB3 polymorphism. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:293 / 295
页数:3
相关论文
共 13 条
[1]   CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis [J].
Barcellos, LF ;
Schito, AM ;
Rimmler, JB ;
Vittinghoff, E ;
Shih, A ;
Lincoln, R ;
Callier, S ;
Elkins, MK ;
Goodkin, DE ;
Haines, JL ;
Pericak-Vance, MA ;
Hauser, SL ;
Oksenberg, JR .
IMMUNOGENETICS, 2000, 51 (4-5) :281-288
[2]   The CCR5 deletion mutation fails to protect against multiple sclerosis [J].
Bennetts, BH ;
Teutsch, SM ;
Buhler, MM ;
Heard, RNS ;
Stewart, GJ .
HUMAN IMMUNOLOGY, 1997, 58 (01) :52-59
[3]   Biotechnological agents for the immunotherapy of multiple sclerosis - Principles, problems and perspectives [J].
Hohlfeld, R .
BRAIN, 1997, 120 :865-916
[4]   The G protein β3 subunit 825T allele is a genetic marker for enhanced T cell response [J].
Lindemann, M ;
Virchow, S ;
Ramann, F ;
Barsegian, V ;
Kreuzfelder, E ;
Siffert, W ;
Müller, N ;
Grosse-Wilde, H .
FEBS LETTERS, 2001, 495 (1-2) :82-86
[5]   Multiple sclerosis: Genomic rewards [J].
Oksenberg, JR ;
Baranzini, SE ;
Barcellos, LF ;
Hauser, SL .
JOURNAL OF NEUROIMMUNOLOGY, 2001, 113 (02) :171-184
[6]   Chemokine receptors: Gateways to inflammation and infection [J].
Premack, BA ;
Schall, TJ .
NATURE MEDICINE, 1996, 2 (11) :1174-1178
[7]   ENHANCED IMMUNOGLOBULIN FORMATION OF IMMORTALIZED B-CELLS FROM HYPERTENSIVE PATIENTS [J].
ROSSKOPF, D ;
HARTUNG, K ;
HENSE, J ;
SIFFERT, W .
HYPERTENSION, 1995, 26 (03) :432-435
[8]   Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene [J].
Samson, M ;
Libert, F ;
Doranz, BJ ;
Rucker, J ;
Liesnard, C ;
Farber, CM ;
Saragosti, S ;
Lapoumeroulie, C ;
Cognaux, J ;
Forceille, C ;
Muyldermans, G ;
Verhofstede, C ;
Burtonboy, G ;
Georges, M ;
Imai, T ;
Rana, S ;
Yi, YJ ;
Smyth, RJ ;
Collman, RG ;
Doms, RW ;
Vassart, G ;
Parmentier, M .
NATURE, 1996, 382 (6593) :722-725
[9]   CCR5 Δ32, matrix metalloproteinase-9 and disease activity in multiple sclerosis [J].
Sellebjerg, F ;
Madsen, HO ;
Jensen, CV ;
Jensen, J ;
Garred, P .
JOURNAL OF NEUROIMMUNOLOGY, 2000, 102 (01) :98-106
[10]  
Siffert W, 1999, J AM SOC NEPHROL, V10, P1921